The DOI matches its Crossref record.
Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils.
Abstract
Adenosine specifically inhibits superoxide anion generation by N-formyl-methionyl-leucyl-phenylalanine-stimulated neutrophils without affecting either degranulation or "aggregation." We present data that also supports the hypothesis that adenosine engages a specific cell surface receptor to mediate inhibition of stimulated neutrophils. Theophylline (10 and 100 mu M), a competitive antagonist at adenosine receptors, reversed the effects of adenosine (0.1 mu M) on superoxide anion generation by stimulated neutrophils. The adenosine analogue 5'N-ethylcarboxamidoadenosine (NECA) was a more potent inhibitor of superoxide anion generation than either N6-phenylisopropyladenosine (PIA) or adenosine, an order of potency consistent with that previously demonstrated for adenosine A2 receptors. 2-Chloroadenosine inhibited superoxide anion generation at concentrations similar to NECA. [3H]-NECA and [3H]-2-chloroadenosine bound to a single receptor on intact neutrophils. The characteristics of the receptors for [3H]-NECA and [3H]-2-chloroadenosine were similar (Kd = 0.22 and 0.23 mu M, respectively; number of binding sites = 9.31 and 11.1 X 10(3) sites/cell, respectively). NECA, 2-chloroadenosine, adenosine, and PIA inhibited binding of [3H]-NECA with a rank order similar to that for inhibition of superoxide anion generation (NECA = 2-chloroadenosine greater than adenosine greater than PIA). There was 50% inhibition of superoxide anion generation by NECA at approximately 20% receptor occupancy. Adenosine, derived from damaged tissues, may serve as a specific, endogenous modulator of superoxide anion generation by activated neutrophils through interaction at this newly described receptor on human neutrophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Self-citationBours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030
Self-citationThe cardiac effects of adenosine
Belardinelli, L., Linden, J., & Berne, R. M. (1989) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(89)90015-7 · Cited by 762
Grace, P. A. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800810504 · Cited by 720
Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 696
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
Vinten-Johansen, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.10.011 · Cited by 680
Cronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Self-citationThe role of neutrophils in myocardial ischemia–reperfusion injury
Jordan, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00187-x · Cited by 646
MOREL, F., DOUSSIERE, J., & VIGNAIS, P. V. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16312.x · Cited by 565
Nathan, C., Srimal, S., Farber, C., Sanchez, E., Kabbash, L., Asch, A., Gailit, J., & Wright, S. D. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.3.1341 · Cited by 556
Cytokine Dysregulation, Inflammation and Well-Being
Elenkov, I. J., Iezzoni, D. G., Daly, A., Harris, A. G., & Chrousos, G. P. (2005) · Neuroimmunomodulation · doi:10.1159/000087104 · Cited by 502
Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., & Revillard, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2676 · Cited by 459
Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process
Moens, A. L., Claeys, M. J., Timmermans, J. P., & Vrints, C. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.04.013 · Cited by 448
Mechanisms of action of methotrexate
Genestier, L., Paillot, R., Quemeneur, L., Izeradjene, K., & Revillard, J.-P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00189-2 · Cited by 424
Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.
Cronstein, B. N., Levin, R. I., Belanoff, J., Weissmann, G., & Hirschhorn, R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112638 · Cited by 412
Self-citationReilly, P. M., Schiller, H. J., & Bulkley, G. B. (1991) · The American Journal of Surgery · doi:10.1016/0002-9610(91)91120-8 · Cited by 380
Cronstein, B. N., Daguma, L., Nichols, D., Hutchison, A. J., & Williams, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114547 · Cited by 376
Self-citationCronstein, B. N., Eberle, M. A., Gruber, H. E., & Levin, R. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2441 · Cited by 332
Self-citationEcto‐enzyme and signaling functions of lymphocyte CD 7 3
Resta, R., Yamashita, Y., & Thompson, L. F. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01574.x · Cited by 332
THE MECHANISM OF ACTION OF METHOTREXATE
Cronstein, B. N. (1997) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70358-6 · Cited by 312
Self-citationPurinergic signalling and immune cells
Burnstock, G., & Boeynaems, J.-M. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9427-2 · Cited by 309
Adenosine in Bronchoalveolar Lavage Fluid in Asthma
Driver, A. G., Kukoly, C. A., Ali, S., & Mustafa, S. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.1.91 · Cited by 307
Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine
KIN, H., ZATTA, A., LOFYE, M., AMERSON, B., HALKOS, M., KERENDI, F., ZHAO, Z., GUYTON, R., HEADRICK, J., & VINTENJOHANSEN, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.02.015 · Cited by 297
Extracellular ATP Induces the Accumulation of Superoxide via NADPH Oxidases in Arabidopsis
Song, C. J., Steinebrunner, I., Wang, X., Stout, S. C., & Roux, S. J. (2006) · Plant Physiology · doi:10.1104/pp.105.073072 · Cited by 295
Tumor-promoting functions of adenosine
Spychala, J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00053-x · Cited by 284
Moens, A. L., Goovaerts, I., Claeys, M. J., & Vrints, C. J. (2005) · Chest · doi:10.1378/chest.127.6.2254 · Cited by 274
Elenkov, I. J. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.037 · Cited by 273
Regulation of Neutrophil Function by Adenosine
Barletta, K. E., Ley, K., & Mehrad, B. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226845 · Cited by 260
Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
Cronstein, B. N., & Sitkovsky, M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.178 · Cited by 258
Self-citationGrover, G. J., Sleph, P. G., & Dzwonczyk, S. (1992) · Circulation · doi:10.1161/01.cir.86.4.1310 · Cited by 256
Metadata
- Authors
- Cronstein, B. N., Rosenstein, E. D., Kramer, S. B., Weissmann, G., & Hirschhorn, R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1985-08-01
- Volume
- 135
- Issue
- 2
- Pages
- 1366-1371
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1486575542
- Cited by
- 345
- References
- 0
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.